FDA Approves Two Ortho Hepatitis B Assays

September 18, 2017

Ortho Clinical Diagnostics received FDA approval for its Vitros HBeAg and Anti-HBe assays for use with the company’s Vitros 5600 and 3600 systems.

Both assays are currently available on the Vitros ECi/ECiQ immunodiagnostic systems.

The assays are used to diagnose individuals with acute or chronic hepatitis B or in recovery from hepatitis B infection.

View today's stories